PL1734927T3 - Kompozycja pianki pimekrolimusa zawierająca glikol heksylenowy, ewentualnie alkohol oleilowy, dimetyloizosorbid oraz/albo triglicerydy o średniej długości łańcucha - Google Patents

Kompozycja pianki pimekrolimusa zawierająca glikol heksylenowy, ewentualnie alkohol oleilowy, dimetyloizosorbid oraz/albo triglicerydy o średniej długości łańcucha

Info

Publication number: PL1734927T3
Authority: PL; Poland
Prior art keywords: dimethylisosorbide; pimecrolimus; composition containing; medium chain; hexylene glycol
Prior art date: 2004-04-08

Application number

PL05733580T

Other languages

English (en)

Inventor

Meir Eini

Doron Friedman

Stefan Hirsch

Sabine Meyenburg

Nabila Sekkat

Dov Tamarkin

Original Assignee

Meda Pharma S A R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-08

Filing date

2005-04-07

Publication date

2012-10-31

2004-04-08 Priority claimed from GB0408070A external-priority patent/GB0408070D0/en

2004-04-08 Priority claimed from GB0408076A external-priority patent/GB0408076D0/en

2005-04-07 Application filed by Meda Pharma S A R L filed Critical Meda Pharma S A R L

2012-10-31 Publication of PL1734927T3 publication Critical patent/PL1734927T3/pl

Links

SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 title 2
MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 title 1
ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 title 1
239000006260 foam Substances 0.000 title 1
229940051250 hexylene glycol Drugs 0.000 title 1
229940057917 medium chain triglycerides Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229940055577 oleyl alcohol Drugs 0.000 title 1
XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 title 1
KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 title 1
229960005330 pimecrolimus Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
Dermatology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Transplantation (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL05733580T 2004-04-08 2005-04-07 Kompozycja pianki pimekrolimusa zawierająca glikol heksylenowy, ewentualnie alkohol oleilowy, dimetyloizosorbid oraz/albo triglicerydy o średniej długości łańcucha PL1734927T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0408070A GB0408070D0 (en)	2004-04-08	2004-04-08	Pharmaceutical formulations
GB0408076A GB0408076D0 (en)	2004-04-08	2004-04-08	Pharmaceutical formulations
PCT/EP2005/003669 WO2005097068A1 (en)	2004-04-08	2005-04-07	Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
EP05733580.4A EP1734927B8 (en)	2004-04-08	2005-04-07	Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides

Publications (1)

Publication Number	Publication Date
PL1734927T3 true PL1734927T3 (pl)	2012-10-31

Family

ID=34964902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05733580T PL1734927T3 (pl)	2004-04-08	2005-04-07	Kompozycja pianki pimekrolimusa zawierająca glikol heksylenowy, ewentualnie alkohol oleilowy, dimetyloizosorbid oraz/albo triglicerydy o średniej długości łańcucha

Country Status (15)

Country	Link
US (1)	US9168224B2 (pl)
EP (1)	EP1734927B8 (pl)
JP (1)	JP5021456B2 (pl)
KR (1)	KR101239446B1 (pl)
AU (1)	AU2005230401B2 (pl)
BR (1)	BRPI0509708B8 (pl)
CA (1)	CA2556993C (pl)
CY (1)	CY1113060T1 (pl)
DK (1)	DK1734927T3 (pl)
ES (1)	ES2389443T3 (pl)
PL (1)	PL1734927T3 (pl)
PT (1)	PT1734927E (pl)
RU (1)	RU2375044C2 (pl)
SI (1)	SI1734927T1 (pl)
WO (1)	WO2005097068A1 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8512718B2 (en)	2000-07-03	2013-08-20	Foamix Ltd.	Pharmaceutical composition for topical application
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US7700076B2 (en)	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US10117812B2 (en)	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en)	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
ES2532906T5 (es)	2002-10-25	2022-03-23	Foamix Pharmaceuticals Ltd	Espuma cosmética y farmacéutica
US8119109B2 (en)	2002-10-25	2012-02-21	Foamix Ltd.	Foamable compositions, kits and methods for hyperhidrosis
US8119150B2 (en)	2002-10-25	2012-02-21	Foamix Ltd.	Non-flammable insecticide composition and uses thereof
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en)	2002-11-29	2015-12-15	Foamix Pharmaceuticals Ltd.	Antibiotic kit and composition and uses thereof
US7820145B2 (en)	2003-08-04	2010-10-26	Foamix Ltd.	Oleaginous pharmaceutical and cosmetic foam
US8486376B2 (en)	2002-10-25	2013-07-16	Foamix Ltd.	Moisturizing foam containing lanolin
US8900554B2 (en)	2002-10-25	2014-12-02	Foamix Pharmaceuticals Ltd.	Foamable composition and uses thereof
US7575739B2 (en)	2003-04-28	2009-08-18	Foamix Ltd.	Foamable iodine composition
US8795693B2 (en)	2003-08-04	2014-08-05	Foamix Ltd.	Compositions with modulating agents
US8486374B2 (en)	2003-08-04	2013-07-16	Foamix Ltd.	Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8211449B2 (en)	2004-06-24	2012-07-03	Dpt Laboratories, Ltd.	Pharmaceutically elegant, topical anhydrous aerosol foam
WO2007039825A2 (en)	2005-05-09	2007-04-12	Foamix Ltd.	Saccharide foamable compositions
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en)	2007-11-30	2016-09-13	Foamix Pharmaceuticals Ltd.	Foam containing benzoyl peroxide
WO2009072007A2 (en) *	2007-12-07	2009-06-11	Foamix Ltd.	Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en)	2007-12-07	2013-08-27	Foamix Ltd.	Oil-based foamable carriers and formulations
EP2242476A2 (en)	2008-01-14	2010-10-27	Foamix Ltd.	Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en)	2009-04-28	2010-11-04	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en)	2009-10-02	2011-06-03	Foamix Ltd.	Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2600783A4 (en)	2010-08-02	2017-05-17	Guided Therapy Systems, L.L.C.	Systems and methods for ultrasound treatment
ES2658897T3 (es)	2011-08-24	2018-03-12	Novan, Inc.	Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
US11813284B2 (en)	2013-08-08	2023-11-14	Novan, Inc.	Topical compositions and methods of using the same
US10322082B2 (en)	2014-07-11	2019-06-18	Novan, Inc.	Topical antiviral compositions and methods of using the same
US10398641B2 (en)	2016-09-08	2019-09-03	Foamix Pharmaceuticals Ltd.	Compositions and methods for treating rosacea and acne

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2198582A (en) *	1937-10-01	1940-04-23	Dow Chemical Co	Ether esters of para hydroxy benzoic acid
US3244589A (en) *	1962-10-26	1966-04-05	Sunnen	Alkyl phenoxy polyethoxy ether spermicidal aerosol
JPH0696522B2 (ja) *	1983-10-24	1994-11-30	ロクリ− サ−ヴイシズプロプライエタリ− リミテツド	起泡型生物致死組成物
US5679324A (en) *	1994-07-08	1997-10-21	The Procter & Gamble Co.	Aerosol foamable fragrance composition
JPH08133979A (ja) *	1994-09-16	1996-05-28	Sando Yakuhin Kk	局所適用薬剤組成物
CN100335063C (zh)	1994-10-26	2007-09-05	诺瓦蒂斯有限公司	药物组合物
JPH10114659A (ja) *	1996-10-11	1998-05-06	Nippon Fine Chem Co Ltd	皮膚外用剤
GB9713730D0 (en) *	1997-06-30	1997-09-03	Ciba Geigy Ag	Organic compounds
JPH11199444A (ja) *	1998-01-09	1999-07-27	Cosmo Products Kk	白髪の予防・治療剤
GB9826656D0 (en) *	1998-12-03	1999-01-27	Novartis Ag	Organic compounds
US6440437B1 (en) *	2000-01-24	2002-08-27	Kimberly-Clark Worldwide, Inc.	Wet wipes having skin health benefits
JP2001097848A (ja) *	1999-09-30	2001-04-10	Kobayashi Pharmaceut Co Ltd	外用剤組成物
GB0003932D0 (en) *	2000-02-18	2000-04-12	Novartis Ag	Pharmaceutical compositions
GB0108498D0 (en) *	2001-04-04	2001-05-23	Novartis Ag	Organic Compounds
GB0218996D0 (en) *	2002-08-14	2002-09-25	Novartis Ag	Organic compounds
US7820145B2 (en) *	2003-08-04	2010-10-26	Foamix Ltd.	Oleaginous pharmaceutical and cosmetic foam

2005
- 2005-04-07 PT PT05733580T patent/PT1734927E/pt unknown
- 2005-04-07 AU AU2005230401A patent/AU2005230401B2/en not_active Ceased
- 2005-04-07 WO PCT/EP2005/003669 patent/WO2005097068A1/en not_active Ceased
- 2005-04-07 SI SI200531566T patent/SI1734927T1/sl unknown
- 2005-04-07 JP JP2007506729A patent/JP5021456B2/ja not_active Expired - Fee Related
- 2005-04-07 PL PL05733580T patent/PL1734927T3/pl unknown
- 2005-04-07 RU RU2006138998/15A patent/RU2375044C2/ru active
- 2005-04-07 DK DK05733580.4T patent/DK1734927T3/da active
- 2005-04-07 KR KR1020067020770A patent/KR101239446B1/ko not_active Expired - Fee Related
- 2005-04-07 CA CA2556993A patent/CA2556993C/en not_active Expired - Fee Related
- 2005-04-07 EP EP05733580.4A patent/EP1734927B8/en not_active Expired - Lifetime
- 2005-04-07 ES ES05733580T patent/ES2389443T3/es not_active Expired - Lifetime
- 2005-04-07 US US11/547,226 patent/US9168224B2/en active Active
- 2005-04-07 BR BRPI0509708A patent/BRPI0509708B8/pt not_active IP Right Cessation
2012
- 2012-08-23 CY CY20121100755T patent/CY1113060T1/el unknown

Also Published As

Publication number	Publication date
KR101239446B1 (ko)	2013-03-06
SI1734927T1 (sl)	2012-09-28
CA2556993C (en)	2013-05-21
US20080181854A1 (en)	2008-07-31
KR20070024507A (ko)	2007-03-02
CY1113060T1 (el)	2016-04-13
AU2005230401B2 (en)	2008-11-27
DK1734927T3 (da)	2012-09-24
WO2005097068A1 (en)	2005-10-20
AU2005230401A1 (en)	2005-10-20
EP1734927A1 (en)	2006-12-27
RU2006138998A (ru)	2008-05-20
HK1099211A1 (en)	2007-08-10
BRPI0509708A (pt)	2007-09-18
PT1734927E (pt)	2012-09-05
RU2375044C2 (ru)	2009-12-10
JP2007532508A (ja)	2007-11-15
EP1734927B8 (en)	2013-10-23
ES2389443T3 (es)	2012-10-26
BRPI0509708B8 (pt)	2021-05-25
US9168224B2 (en)	2015-10-27
BRPI0509708B1 (pt)	2018-12-04
JP5021456B2 (ja)	2012-09-05
EP1734927B1 (en)	2012-06-13
CA2556993A1 (en)	2005-10-20

Publication	Publication Date	Title
SI1734927T1 (sl)	2012-09-28	Pimekrolimusni penjen sestavek, ki vsebuje heksilenglikol, po izbiri oleil alkohol, dimetilizosorbid in/ali srednjeveriĹľne trigliceride
ZA200509760B (en)	2006-11-29	Composition for maintaining organ and cell viability
ZA200704396B (en)	2008-10-29	Pumped foam containing alcohol
EP1718307A4 (en)	2009-04-29	IMMUNE REPRESENTING COMPOUNDS AND COMPOSITIONS
HUE037643T2 (hu)	2018-09-28	Visszaélésre nem alkalmas gyógyszerkészítmények
GB2429717B (en)	2009-04-08	Cell preservation method
EP1678231A4 (en)	2009-12-09	VISCOELASTIC FOAM LAYER AND COMPOSITION
EP1718604A4 (en)	2008-02-13	COMPOUNDS AND COMPOSITIONS OF IMMUNOSUPPRESSANTS
PL1765239T3 (pl)	2013-10-31	Struktura warstwy chłonnej
AP2006003693A0 (en)	2006-08-31	Substituted quinolines and their use as mycobacterial inhibitors
ZA200701527B (en)	2008-10-29	Composition comprising statin
ZA200608311B (en)	2008-12-31	Composition comprising statins
GB2422287B (en)	2007-06-13	Preservative and embalming fluids
EP1817110A4 (en)	2010-02-17	METHOD AND APPARATUS FOR STORING MICROPLATES
GB0403008D0 (en)	2004-03-17	Composition and method
ZA200702966B (en)	2008-09-25	Cryopreservation of cells
GB0514922D0 (en)	2005-08-24	Slide bearing layer
GB0422570D0 (en)	2004-11-10	Device with storage medium and method of operating the device
ZA200706038B (en)	2008-12-31	Visco-supplement composition and methods
EP1596815A3 (en)	2005-10-27	Composition and methods for inhibiting cell survival
EP1946759A4 (en)	2009-12-23	THERAPEUTIC AGENT AGAINST NAUSEUM AND / OR VOMITING
GB0417925D0 (en)	2004-09-15	Preservation composition
GB0413417D0 (en)	2004-07-21	Cold storage apparatus
TWI318223B (en)	2009-12-11	Diffusion film
HU2892U (en)	2005-03-29	Chess-set filled with alcoholic-drink